STAGE II BLADDER CANCER AJCC V8
Clinical trials for STAGE II BLADDER CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE II BLADDER CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE II BLADDER CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could fewer radiation sessions be just as effective for bladder cancer?
Disease control Recruiting nowThis study compares a standard course of radiation therapy (given over several weeks) with a much shorter course (just a few treatments) for people with muscle invasive bladder cancer. Both groups also receive chemotherapy. The goal is to see if the shorter radiation schedule wor…
Matched conditions: STAGE II BLADDER CANCER AJCC V8
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 26, 2026 05:51 UTC
-
New drug duo offers hope for bladder cancer patients who can't take chemo
Disease control Recruiting nowThis study tests whether combining futibatinib (a targeted therapy) with durvalumab (an immunotherapy) before bladder removal surgery can help people with muscle-invasive bladder cancer who cannot receive standard cisplatin chemotherapy. About 24 participants will receive the dru…
Matched conditions: STAGE II BLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: Yuanquan Yang • Aim: Disease control
Last updated May 26, 2026 05:48 UTC
-
New Bladder-Sparing combo shows promise in fighting aggressive cancer
Disease control Recruiting nowThis study tests a combination of two drugs (enfortumab vedotin and pembrolizumab) plus radiation therapy for people with muscle invasive bladder cancer. The goal is to kill the cancer while allowing patients to keep their bladder, avoiding the standard surgery to remove it. Abou…
Matched conditions: STAGE II BLADDER CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Bladder cancer patients may avoid surgery with new combo therapy
Disease control Recruiting nowThis study tests whether giving the immunotherapy drug pembrolizumab together with radiation therapy after chemotherapy can help people with muscle invasive bladder cancer keep their bladder instead of having it surgically removed. About 111 participants will receive the combinat…
Matched conditions: STAGE II BLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 18, 2026 12:04 UTC